Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc
 
 
Facebook
 
ME/CFS SOUTH AUSTRALIA INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?
 

Gearing up for the big search for XMRV

Tuesday 23 November 2010

Test tubesFrom The Wall Street Journal's Health Blog:

Gearing Up for the Big Search for XMRV

By Amy Dockser Marcus
NOVEMBER 17, 2010, 12:50 PM ET

Since a group of researchers published a paper in Science last year suggesting the retrovirus XMRV is linked to chronic fatigue syndrome, scientists have been debating the accuracy of that finding. Now a study designed to address that issue once and for all is moving forward.

Clinicians who treat CFS patients, scientists and others convened recently in New York, where virus hunter Ian Lipkin is based. Lipkin was asked by NIH and NIAID to head up the study.

At least three labs have agreed to test fresh blood samples for XMRV. Two labs, at FDA/NIH and the Whittemore-Peterson Institute, have previously found XMRV or related viruses in patients. The third lab, at the CDC, has not.

Clinicians who treat patients in different regions of the country, including Miami, Boston, Palo Alto, and Salt Lake City, will be collecting the blood from both healthy people and CFS patients.

Lipkin tells the Health Blog that the study focuses on whether XMRV or other viruses in the same family are found in higher frequency in patients with CFS.

As a starting point, everyone had to agree on how to define a CFS patient for the purposes of the study. The issue has been highly contentious and Lipkin says they tried to agree to criteria for patient selection that “includes everyone’s viewpoints.”

The solution: the study will seek to enroll people who in addition to meeting criteria for two widely used, symptom-based definitions of CFS, showed signs of infection — such as a sore throat or tender lymph nodes — around the time they developed CFS. The thought is that if there is a viral link to CFS, it’s most likely to show up in those patients.

More work still needs to be done. The physicians participating in the study will meet with Lipkin in coming weeks to develop a standard checklist for evaluating patients. The scientists are still working out a common protocol for how they handle and process the blood. But Lipkin tells the Health Blog that everything they are doing is designed to make it possible to finally end the debate over whether XMRV is associated with CFS.

The above originally appeared here.

 


Arrow right

XMRV in the News

 


 

blog comments powered by Disqus
Previous Previous Page